 | Thank you for being a valued part of the CNET community. As of December 1, 2020, the forums are in read-only format. In early 2021, CNET Forums will no longer be available. We are grateful for the participation and advice you have provided to one another over the years. Thanks, CNET Support |
TORONTO - Canada has become the first country in the world to approve a cannabis-based painkiller for patients suffering multiple sclerosis, a move applauded by those with the disease and proponents of medical uses for marijuana
this is very good news for the sufferers i hope the usa will lossen up
http://www.chron.com/cs/CDA/ssistory.mpl/headline/world/3145392
Discussion is locked
Since I have multiple sclerosis more than one co-worker told me about this today. However, I am not in any pain so the treatment will not do me any good. MS has a nice wide variety of symptoms, and new ones crop up as the disease progresses.
Like Forrest Gump's box of chocolates, you never know what you're going to get. Some people with MS suffer constant, excruciating pain and some like me (so far, knock on wood) have none.
Of course I keep an eye on the scene and I am happy to say that there is a lot of great research being done and there are newer, better treatments in the pipeline. Some days I even dare hope for a cure. Never despair.
... pharmaceuticalized MJ is not what a large chunk of the MJ legalization folks want. The more such meds become available, the more the medicinal use of MJ argument falls by the wayside.
What I find confusing is that the article seems to imply that this is a first for cannabis-based pharmaceuticals. It isn't. Marinol has been around in the US for quite a while, although its benefits are as an anti-emetic and appetite stimulant. If this painkiller is less addictive than the codeine-related ones, I see no reason it won't make it to the US market soon. The use of drugs with recreational uses for medicinal purposes is nothing all that new.
Evie 
Chowhound
Comic Vine
GameFAQs
GameSpot
Giant Bomb
TechRepublic